Evidence map›Paper›PMID 32657536›Full record

ReviewChemMedChem2020

New Antivirals and Antibacterials Based on Silver Nanoparticles.

Rosaria Ciriminna, Yael Albo, Mario Pagliaro

Abstract readReview
In one paragraph

Review in ChemMedChem, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Selected strategies to fight pathogenic bacteria.Journal of enzyme inhibition and medicinal chemistry · 2023
    Review
  9. Article
  10. Article
  11. Metals to combat antimicrobial resistance.Nature reviews. Chemistry · 2023
    Review
  12. Review
  13. Nanoparticles: Taking a Unique Position in Medicine.Nanomaterials (Basel, Switzerland) · 2023
    Review
  14. Article
  15. Article
  16. Journal of fungi (Basel, Switzerland) · 2022
    Article
  17. Article
  18. Nanotechnology: A Potential Weapon to Fight against COVID-19.Particle & particle systems characterization : measurement and description of particle properties and behavior in powders and other disperse systems · 2022
    Review
  19. Review
  20. Inorganic Nanoparticles and Composite Films for Antimicrobial Therapies.International journal of molecular sciences · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Rosaria CiriminnaIstituto per lo Studio dei Materiali Nanostrutturati, CNR, via U. La Malfa 153, 90146, Palermo, Italy.ORCID 0000-0001-6596-1572
Yael AlboDepartment Chemical Engineering, Materials and Biotechnology The Center for Radical Reactions, Ariel University, Jerusalem, Israel.ORCID 0000-0003-0701-3827
Mario PagliaroIstituto per lo Studio dei Materiali Nanostrutturati, CNR, via U. La Malfa 153, 90146, Palermo, Italy.ORCID 0000-0002-5096-329X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rediscovery of the medical uses of silver provides another noticeable example, this time at the interface of chemistry and medicine, of the real (and nonlinear) progress of scientific research. Several new silver-based antimicrobial products have thus been commercialized in the last two decades. Next-generation antibacterials and antivirals of broad scope, low toxicity and affordable cost, we argue in this study, will be based on microencapsulated Ag nanoparticles.

Indexed as

Anti-Bacterial AgentsAntiviral AgentsBacteriaMetal NanoparticlesMicrobial Sensitivity TestsParticle SizeSilverVirusesAnti-Bacterial AgentsAntiviral AgentsSilverantibacterial agentsantiviral agentsmicroencapsulationnanoparticlessilversol-gel

Identifiers

PMID32657536
PMCPMC7404954

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.